Wide-Moat Stocks: Companies Dominating Their Markets
Warren Buffett popularized the concept of an economic moat — a durable competitive advantage that protects a company’s profits and market share from rivals over time, much like the water surrounding a medieval castle protected its inhabitants. Morningstar later formalized the idea into a three-tier rating system: wide moat (advantages expected to last 20+ years), narrow moat (at least 10 years), and no moat.
Morningstar identifies five sources from which a moat can be derived:
- Network effect: The product becomes more valuable as more people use it — Visa, Mastercard, and Meta are classic examples.
- Intangible assets: Patents, brands, and regulatory licenses that block competitors — Coca-Cola’s brand power and Moody’s regulatory standing fall here.
- Switching costs: Customers face high costs or friction when changing providers — Microsoft’s enterprise software suite is a textbook case.
- Cost advantage: Structural cost efficiencies that competitors cannot replicate — Waste Management’s vertically integrated network of landfills, recycling centers, and exclusive municipal licenses is nearly impossible for new entrants to match.
- Efficient scale: Markets that naturally support only one or a few players — Union Pacific in railroads and ASML in extreme ultraviolet lithography, where it holds a near-monopoly on EUV systems essential for producing the most advanced semiconductor chips.
Wide-moat companies cluster heavily in technology, healthcare, consumer staples, financials, and industrials. Six of the Magnificent Seven — Nvidia, Meta Platforms, Apple, Amazon, Microsoft, and Alphabet — carry wide-moat designations. Beyond tech, names like LVMH, Novo Nordisk, and Ferrari maintain advantages rooted in heritage, patents, and exclusivity that competitors simply cannot replicate.
For those interested in a fund-based approach, the VanEck Morningstar Wide Moat ETF (MOAT) tracks the Morningstar Wide Moat Focus Index, which selects attractively priced companies with wide-moat ratings and rebalances quarterly across two staggered sub-portfolios of 40 stocks each.
Regulated brokerThe table below lists companies with unrivalled economic moats — businesses with dominant, hard-to-replicate market positions. All data including price and market cap are updated regularly.
| Stock | Price | Change % | Marketcap |
|---|---|---|---|
Gilead Sciences GILD | $123.76 | 1.35% | 153.66B |
Boeing BA | $222.72 | 1.29% | 175.57B |
GE HealthCare Technologies GEHC | $61.59 | 0.72% | 28.02B |
Walt Disney DIS | $103.89 | 3.00% | 180.41B |
Corteva CTVA | $78.59 | 1.58% | 52.56B |
Bristol-Myers Squibb BMY | $54.00 | 2.32% | 110.27B |
Alphabet (Google) GOOG | $367.46 | 1.48% | 4.48T |
Veeva Systems VEEV | $153.30 | 1.00% | 24.90B |
Altria Group MO | $69.12 | 0.25% | 115.42B |
TransUnion TRU | $64.60 | 0.25% | 12.45B |
U.S. Bancorp USB | $58.14 | 0.40% | 90.57B |
Agilent Technologies A | $127.06 | 2.20% | 35.89B |
NXP Semiconductors NXPI | $313.27 | 5.05% | 79.09B |
Allegion ALLE | $133.57 | 2.60% | 11.48B |
Kenvue KVUE | $18.12 | 0.61% | 34.79B |
Zimmer Biomet ZBH | $87.97 | 0.93% | 17.02B |
Pfizer PFE | $25.21 | 2.74% | 143.68B |
Bio-Rad Laboratories BIO | $282.44 | 0.78% | 7.56B |
Nike NKE | $45.20 | 2.29% | 66.94B |
International Flavors & Fragrances IFF | $76.72 | 1.41% | 19.59B |
United Parcel Service UPS | $104.86 | 0.26% | 89.13B |
Teradyne TER | $437.92 | 7.19% | 68.55B |
Estee Lauder EL | $84.81 | 2.85% | 30.68B |
Campbell Soup CPB | $21.15 | 0.19% | 6.31B |
Adobe ADBE | $195.16 | 0.57% | 77.58B |
Microchip Technology MCHP | $99.77 | 6.01% | 54.08B |
MarketAxess MKTX | $120.33 | 0.36% | 4.28B |
Huntington Ingalls Industries HII | $285.43 | 3.86% | 11.25B |
Brown Forman Inc BF-B | $26.64 | 4.43% | 12.22B |
Salesforce CRM | $151.78 | 2.09% | 124.31B |
Charles Schwab SCHW | $91.70 | 2.97% | 159.48B |
Emerson EMR | $150.66 | 1.11% | 84.38B |
Amazon AMZN | $244.39 | 2.90% | 2.63T |
Monolithic Power Systems MPWR | $1,563.70 | 7.97% | 76.82B |
Autodesk ADSK | $193.82 | 0.39% | 40.92B |
Air Products and Chemicals APD | $280.21 | 0.55% | 62.40B |
Amgen AMGN | $337.60 | 1.19% | 182.21B |
Otis Worldwide OTIS | $73.27 | 0.76% | 28.11B |
Thermo Fisher Scientific TMO | $464.61 | 0.63% | 172.66B |
Lam Research LRCX | $389.04 | 3.97% | 486.52B |
Masco MAS | $74.38 | 2.42% | 15.01B |
Mondelez MDLZ | $60.12 | 1.22% | 77.17B |
Honeywell HON | $229.01 | 0.17% | 145.11B |
Northrop Grumman NOC | $521.50 | 5.21% | 74.07B |
Equifax EFX | $153.93 | 0.59% | 18.57B |
IDEX IEX | $224.93 | 0.55% | 16.65B |
Microsoft MSFT | $379.40 | 0.13% | 2.82T |
Danaher DHR | $177.17 | 0.33% | 125.40B |
Merck MRK | $113.87 | 1.36% | 281.24B |
Constellation Brands STZ | $141.18 | 1.60% | 24.31B |
West Pharmaceutical WST | $327.95 | 1.35% | 23.17B |
Apple AAPL | $298.01 | 0.70% | 4.38T |
